TL;DR
This paper introduces an optimized adaptive optics two-photon fluorescence microscope (AO-2PFM) that overcomes the optical limitations of the mouse eye, enabling unprecedented high-resolution, in vivo imaging of retinal microvasculature and neuronal activity. This advancement allows for detailed longitudinal studies of retinal diseases and drug responses in living mice, paving the way for improved diagnosis and treatment strategies.
What Problem Does This Paper Address?
The retina, a crucial neural tissue for vision, is notoriously difficult to image at high resolution in vivo in mice due to significant optical aberrations introduced by the mouse eye itself (cornea, lens). These aberrations blur images, preventing visualization of fine structures like synapses and capillaries, and hindering the study of dynamic pathological processes or drug effects in real-time. While two-photon fluorescence microscopy (2PFM) is a powerful tool for deep tissue imaging, its effectiveness in the mouse retina is severely limited by these aberrations. Consequently, many studies rely on ex vivo imaging of dissected retinas, which sacrifices the ability to observe dynamic processes in a living organism. This paper aims to bridge this gap by developing and validating an AO-2PFM system specifically tailored for in vivo mouse retinal imaging.
Methods
The core of this work is the development and characterization of an Adaptive Optics Two-Photon Fluorescence Microscope (AO-2PFM). Key methodological components include:
- Optimized 2PFM System Design: The authors built a custom 2PFM system incorporating an eye imaging module designed to work with the mouse eye's optics. This module includes an electrically tunable lens (ETL) for focal plane adjustment without moving the sample or microscope.
- Direct Wavefront Sensing and Correction: A Shack-Hartmann sensor is used to measure the optical aberrations introduced by the mouse eye. These aberrations are then computationally reconstructed and corrected in real-time using a deformable mirror (DM).
- Sample Preparation: A custom-designed 0-diopter contact lens with a supportive flat base and eye gel was developed. This crucial step minimizes corneal aberrations, prevents cataract formation, and allows for stable, hours-long imaging.
- Longitudinal Imaging: The AO-2PFM system is designed for repeated imaging of the same retinal region over time, crucial for tracking disease progression and treatment effects.
- Model Systems: The system was validated using transgenic mouse models:
- Thy1-GFP/YFP lines: For visualizing retinal neurons and their fine processes, including synapses.
- VLDLR-KO/Sca1-GFP mice: A model for proliferative vascular retinopathy to study microvascular lesions.
- rdl-Thy1-GCaMP6s mice: A model for retinal degeneration to study neuronal hyperactivity and drug effects.
Datasets
The paper does not train models on datasets. Instead, it utilizes in vivo imaging data from genetically modified mouse models. The data generated are the high-resolution images and functional readouts (calcium imaging) from these living animals.
Key Insights and Ideas
- Mouse Eye Aberrations are Significant but Correctable: The study confirms that mouse eye aberrations are substantial, but demonstrates that direct wavefront sensing and adaptive optics can effectively correct them, achieving near diffraction-limited resolution.
- AO is Crucial for Subcellular and Functional Imaging: While basic vascular structures might be visible without AO in some cases, resolving fine capillaries, synaptic structures, and performing high-fidelity functional imaging (like calcium dynamics) in vivo absolutely requires AO.
- Optimized Sample Prep is Key: The development of a specific contact lens and eye gel combination was critical for both image quality and stable, long-term in vivo imaging.
- Field-Dependent Aberrations: Aberrations vary across the field of view, necessitating either localized AO correction or a strategy for global correction to cover larger areas.
- AO Enables Novel Disease and Pharmacology Studies: The AO-2PFM system opens doors to studying microvascular lesions with sub-capillary detail, tracking immune cell migration in disease models, and precisely evaluating the effects of drugs on neuronal activity in vivo.
Key Results
- Resolution Enhancement: Achieved lateral resolution better than ~0.8 µm for RGC axons and axial resolution of 6.7 µm, close to theoretical limits.
- Vascular Imaging: Enabled in vivo visualization of retinal microvasculature with sub-capillary details, identifying capillary disruptions in a VLDLR-KO mouse model associated with dye leakage.
- Neuronal Imaging: Allowed for the first in vivo visualization of retinal synaptic structures and high-resolution 3D cellular imaging of neurons, differentiating retinal layers.
- Pharmacology: Demonstrated the ability to track Lidocaine's suppression of RGC hyperactivity in a retinal degeneration model in vivo, providing a cellular-level understanding of drug effects.
- Effective AO Area: Characterized the effective area of AO correction, showing that global correction strategies can enable 3D cellular resolution imaging over larger retinal volumes.
Limitations and Future Work
- Field of View Limitations: While AO significantly improves resolution, the effective area for correction with a single measurement is limited. The paper explores strategies like stitching images or using larger wavefront sensing areas to address this, but it remains an area for further optimization.
- System Complexity: While the paper presents an optimized system, AO-2PFM is inherently more complex than standard microscopy.
- Future Work: The authors envision AO-enabled high-sensitivity subcellular and cellular 2PFM imaging becoming a highly enabling technology for pathological and pharmacological investigations of the mouse retina in vivo. They suggest incorporating high-performance scan lenses to further increase the effective AO area and imaging FOV. The demonstrated capabilities point towards applications in early disease diagnosis and the development of new therapeutic interventions.
Summary updated